HF
DAWN

HRT Financial’s Day One Biopharmaceuticals DAWN Stock Holding History

HRT Financial’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$813K Sell
37,944
-412,994
-92% -$5.82M ﹤0.01% 2186
2025
Q4 		$4.2M Buy
450,938
+129,561
+40% +$1.08M 0.01% 863
2025
Q3 		$2.27M Buy
+321,377
New +$2.21M 0.01% 1078
2025
Q2 		– Sell
-31,487
Closed -$249K – 2782
2025
Q1 		$249K Buy
+31,487
New +$339K ﹤0.01% 1878
2024
Q3 		– Sell
-98,624
Closed -$1.36M – 2552
2024
Q2 		$1.36M Buy
+98,624
New +$1.44M 0.01% 876
2024
Q1 		– Sell
-73,887
Closed -$1.08M – 2461
2023
Q4 		$1.08M Buy
+73,887
New +$896K 0.01% 944
2022
Q3 		– Sell
-35,426
Closed -$634K – 2937
2022
Q2 		$634K Buy
+35,426
New +$366K 0.01% 1318

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

HRT Financial's DAWN Position: Q1 2026 in Review

HRT Financial reduced its Day One Biopharmaceuticals (DAWN) stake by 92% in Q1 2026, selling an estimated $5.82M and leaving 37,944 shares worth $813K. The position accounts for ﹤0.01% of the portfolio, ranked #2186.

HRT Financial first reported a position in DAWN in Q2 2022 and has held it in 7 quarters since. The position peaked at $4.2M in Q4 2025. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • HRT Financial held 37,944 shares of Day One Biopharmaceuticals worth $813K as of Q1 2026.
  • HRT Financial sold 412,994 Day One Biopharmaceuticals shares in Q1 2026, an estimated $5.82M.
  • Day One Biopharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2186 holding.
  • HRT Financial first reported a position in Day One Biopharmaceuticals in Q2 2022 and has held it in 7 quarters since.
  • HRT Financial's Day One Biopharmaceuticals position peaked at $4.2M in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.